*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p>Vatalanib succinate is a potent, orally active small-molecule inhibitor targeting vascular endothelial growth factor receptors (VEGFRs). Synthesized via salt formation of the free base with succinic acid, its molecular formula is <strong>C<sub>25</sub>H<sub>29</sub>N<sub>7</sub>O<sub>4</sub>S</strong> and CAS number is <strong>102863-92-5</strong>.</p>
<h3>Application</h3>
<ul>
<li><strong>Oncology Research:</strong> Investigational agent for solid tumors including renal cell carcinoma.</li>
<li><strong>Drug Development:</strong> Used in preclinical studies to evaluate anti-angiogenic efficacy.</li>
<li><strong>Biochemical Analysis:</strong> Serves as a standard reference compound for pharmacological assays.</li>
</ul>
<h3>Precautions</h3>
<p>Strictly for research use only; not approved for human clinical therapy. Store at <strong>-20°C</strong> under inert atmosphere. Handle with appropriate PPE to avoid inhalation or skin contact due to potential cytotoxicity.</p>